
-- | |
$37.96 | |
$49.97 | |
$23.00 | |
$35.00 | |
$-2.75 | |
-7.86% | |
90K |
Obsidian Therapeutics, Inc. (OBX) is currently trading at $32.25 as of 2026-08-11 20:22:00, reflecting a -7.86% move ($-2.75) from the previous close.
In the short term, the stock has returned -5.15% over the past four weeks. Over the last 12 months, Obsidian Therapeutics, Inc. has recorded a -5.15% price change, indicating a Weak performance relative to the broader market.
Over the past seven days, Obsidian Therapeutics, Inc. has traded within a short-term range shaped by market sentiment in the sector. During this period, the stock moved from its previous closing price of $30.00 to the latest recorded price of $32.25, reflecting an intraday change of -7.86%. Daily movements highlight shifts in trading volume (89,920), investor positioning, and reactions to macroeconomic updates.
From a momentum standpoint, OBX has delivered a -5.15% return over the past month and a -5.15% change in the last 12 months, indicating a Weak trend relative to its broader sector peers.
You can buy and trade OBX on MEXC in three simple steps:
Obsidian Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered tumor infiltrating lymphocytes (TIL) cell therapies for the treatment of patients with solid tumors. The company's proprietary cytoDRiVE platform is versatile and allows it to leverage drug responsive domains to control protein function, with its initial focus on TIL cell therapies developed from this platform (cytoTILs). The company's flagship product candidate, OBX-115, is a novel, genetically engineered, autologous TIL cell therapy currently in a Phase 2 clinical trial for the treatment of melanoma and a Phase 1 clinical trial for the treatment of non-small cell lung cancer.
| Industry | -- |
| Employees | -- |
| Sector | -- |
| Company Website |
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.